{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:42Z","timestamp":1761560022241},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/eye.2016.29","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T10:32:12Z","timestamp":1458297132000},"page":"515-521","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium"],"prefix":"10.1038","volume":"30","author":[{"given":"C O","family":"Bekibele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T F","family":"Sarimiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ogundipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Olaniyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"BFeye201629_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/bjo.68.5.343","volume":"68","author":"DJ Moran","year":"1984","unstructured":"Moran DJ, Hollows FC . Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol 1984; 68: 343\u2013346.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201629_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1001\/archopht.1992.01080130101035","volume":"110","author":"HR Taylor","year":"1992","unstructured":"Taylor HR, West S, Munoz B . The long-term effects of visible light on the eye. Arch Ophthalmol 1992; 110: 99\u2013104.","journal-title":"Arch Ophthalmol"},{"key":"BFeye201629_CR3","unstructured":"Cameron ME . Pterygium throughout the world. Charles C. Thomas: Springfield, Illinois, USA, 1965."},{"key":"BFeye201629_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/bjo.32.2.65","volume":"32","author":"A D\u2019 Ombrain","year":"1948","unstructured":"D\u2019 Ombrain A . The surgical treatment of pterygium. Br J Ophthalmol 1948; 32: 65\u201371.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201629_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/bjo.56.2.120","volume":"56","author":"RM Youngson","year":"1972","unstructured":"Youngson RM . Recurrence of pterygium after excision. Br J Ophthalmol 1972; 56: 120\u2013125.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"BFeye201629_CR6","first-page":"23","volume":"3","author":"A Kutbaab","year":"2008","unstructured":"Kutbaab A, Ardekani HA, Khoshniyat H, Hosseini HJ . Amniotic membrane transplantation for primary pterygium surgery. J Ophthalmic Vis Res 2008; 3 (1): 23\u201327.","journal-title":"J Ophthalmic Vis Res"},{"key":"BFeye201629_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bjo.2006.102905","volume":"91","author":"EC Figueira","year":"2007","unstructured":"Figueira EC, Coroneo MT, Francis IC . Preventing conjunctival autograft inversion in pterygium surgery. Br J Ophthalmol 2007; 91: 83\u201384.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201629_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0161-6420(85)33831-9","volume":"92","author":"KR Kenyon","year":"1985","unstructured":"Kenyon KR, Wagoner MD, Hettinger ME . Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985; 92: 1461\u20131470.","journal-title":"Ophthalmology"},{"key":"BFeye201629_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0161-6420(94)31369-8","volume":"101","author":"JA McCoombes","year":"1994","unstructured":"McCoombes JA, Hirst LW, Isbell GP . Sliding conjunctival flap for the treatment of primary pterygium. Ophthalmology 1994; 101: 169\u2013173.","journal-title":"Ophthalmology"},{"key":"BFeye201629_CR10","first-page":"9","volume":"31","author":"BG Ajayi","year":"2002","unstructured":"Ajayi BG, Bekibele CO . Evaluation of the effectiveness of postoperative beta irradiation in the management of pterygium. Afr J Med Med Sci 2002; 31: 9\u201311.","journal-title":"Afr J Med Med Sci"},{"key":"BFeye201629_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.ijrobp.2003.12.021","volume":"59","author":"IM Jurgenliemk-Schulz","year":"2004","unstructured":"Jurgenliemk-Schulz IM, Hartman IJ, Roesink JM, Tersteeg RJ, Van der Tweel I, Kal HB et al. Prevention of pterygium recurrence by postoperative single dose beta irradiation: A prospective randomized clinical double blind trial. Int J Radiat Oncol Biol Phys 2004; 59: 1138\u20131147.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFeye201629_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0002-9394(14)72957-5","volume":"118","author":"S Smith","year":"1994","unstructured":"Smith S, D\u2019Amore PA, Dreyer EB . Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 1994; 118: 332\u2013337.","journal-title":"Am J Ophthalmol"},{"key":"BFeye201629_CR13","first-page":"414","volume":"2","author":"KH Chen","year":"2006","unstructured":"Chen KH, Hsu WM . Intraoperative ethanol treatment as an adjuvant therapy of pterygium excision. Int J Biomed Sci 2006; 2: 414\u2013421.","journal-title":"Int J Biomed Sci"},{"key":"BFeye201629_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3892\/ijmm_00000371","volume":"25","author":"ET Detorakis","year":"2010","unstructured":"Detorakis ET, Zaravinos A, Spandidos DA . Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med 2010; 25: 513\u2013516.","journal-title":"Int J Mol Med"},{"key":"BFeye201629_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2010.30.2729","volume":"29","author":"A Lai","year":"2011","unstructured":"Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 2011; 29: 142\u2013148.","journal-title":"J Clin Oncol"},{"key":"BFeye201629_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/JTO.0b013e318200f9c5","volume":"6","author":"TE Stinchcombe","year":"2011","unstructured":"Stinchcombe TE, Socinski MA . Maintenance therapy in advanced non-small cell lung cancer: current status and future implications. J Thorac Oncol 2011; 6: 174\u2013182.","journal-title":"J Thorac Oncol"},{"key":"BFeye201629_CR17","first-page":"4767","volume":"30","author":"NI Barrena Medel","year":"2010","unstructured":"Barrena Medel NI, Herzog TJ, Wright JD, Lewin SN . Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report. Anticancer Res 2010; 30: 4767\u20134768.","journal-title":"Anticancer Res"},{"key":"BFeye201629_CR18","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S1470-2045(10)70259-X","volume":"11","author":"T Fojo","year":"2010","unstructured":"Fojo T, Wilkerson J . Bevacizumab and breast cancer: the E2100 outlier. Lancet Oncol 2010; 11: 1117\u20131119.","journal-title":"Lancet Oncol"},{"key":"BFeye201629_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1755-3768.2010.02010.x","volume":"89","author":"M Waisbourd","year":"2011","unstructured":"Waisbourd M, Goldstein M, Loewenstein A . Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol 2011; 89: 203\u2013207.","journal-title":"Acta Ophthalmol"},{"key":"BFeye201629_CR20","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/bjo.2009.173732","volume":"94","author":"MS Figueroa","year":"2010","unstructured":"Figueroa MS, Contreras I, Noval S, Arruabarrena C . Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol 2010; 94: 1052\u20131056.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201629_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-008-0952-y","volume":"247","author":"JS Schouten","year":"2009","unstructured":"Schouten JS, La Heij EC, Webers CA, Lundqvist IJ, Hendrikse F . A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye201629_CR22","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1755-3768.2009.01571.x","volume":"88","author":"Z Habot-Wilner","year":"2010","unstructured":"Habot-Wilner Z, Barequet IS, Ivanir Y, Moisseiev J, Rosner M . The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization. Acta Ophthalmol 2010; 88: 862\u2013867.","journal-title":"Acta Ophthalmol"},{"key":"BFeye201629_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ceo.12140","volume":"42","author":"A Nava-Casta\u00f1eda","year":"2014","unstructured":"Nava-Casta\u00f1eda A, Olvera-Morales O, Ramos-Castellon C, Garnica-Hayashi L, Garfias Y . Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up. Clin Experiment Ophthalmol 2014; 42: 235\u2013241.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"1","key":"BFeye201629_CR24","first-page":"22","volume":"9","author":"R Mohammad-Reza","year":"2014","unstructured":"Mohammad-Reza R, Mohammad B . Subconjunctival bevacizumab for primary pterygium excision, a randomized clinical trial. J Ophthalmic Vis Res 2014; 9 (1): 22\u201330.","journal-title":"J Ophthalmic Vis Res"},{"key":"BFeye201629_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.eye.6702480","volume":"22","author":"CO Bekibele","year":"2008","unstructured":"Bekibele CO, Baiyeroju AM, Olusanya BA, Ashaye AO, Oluleye TS . Pterygium treatment using 5-FU as adjunct treatment compared to conjunctiva autograft. Eye 2008; 22: 31\u201334.","journal-title":"Eye"},{"key":"BFeye201629_CR26","first-page":"1849","volume":"6","author":"AA Kareem","year":"2012","unstructured":"Kareem AA, Farhood QK, Alhammami HA . The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium. Clin Ophthalmol 2012; 6: 1849\u20131854.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"BFeye201629_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10792-011-9509-x","volume":"32","author":"CO Bekibele","year":"2012","unstructured":"Bekibele CO, Ashaye A, Olusanya B, Baiyeroju AM, Fasina O, Ibrahim AO et al. 5-Fluorouracil versus mitomycin C as adjunct to conjunctival autograft in preventing pterygium recurrence. Int Ophthalmol 2012; 32 (1): 3\u20138.","journal-title":"Int Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201629","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:29:10Z","timestamp":1684430950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFeye201629"],"URL":"https:\/\/doi.org\/10.1038\/eye.2016.29","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]},"assertion":[{"value":"22 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}